02/07/2023
A recent retrospective observational real-world study examined the safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain.
The study concluded: "Oral cannabinoid therapy seems to be safe and mildly effective in patients with TRCP. Randomized controlled trials with focus on comparable pain characteristics in diagnostical homogenous patient subgroups are needed for further improvement of evidence level for relief of chronic pain using oral cannabinoids.”
Horsted, T., Hesthaven, K. L., & Leutscher, P. D. C. (2023). Safety and effectiveness of cannabinoids to Danish patients with treatment refractory chronic pain—A retrospective observational real‐world study. European Journal of Pain, 27(2), 234-247.